New York Prostate Institute Home Page
ABOUT PROSTATE
CANCER
NYPI RESEARCH
STUDIES
PATIENT
RESOURCES
FOR
PHYSICIANS
TREATMENT
OPTIONS
FREQUENTLY ASKED
QUESTIONS





FREQUENTLY ASKED QUESTIONS
What is prostate cancer?
What's new in prostate cancer?
How best to determine my treatment options?
What are the radiation safety issues that are important?
Do I need hormones with my treatment?
What is expected in terms of survival & biochemical outcome?
What side effects are common?

dots

ONLINE GLOSSARY
Search for the definition of any medical term or phrase. Partial terms (ie med) are okay. Enter a keyword then click search.

E-mail this page
Print this page
View page in plain text
Make body copy font larger
Make body copy font smaller
blank iimage
What is prostate cancer?

Except for skin cancer, cancer of the prostate is the most common malignancy in American men. It is estimated that nearly 221,000 men in the United States will be diagnosed with prostate cancer in 2003. In most men with prostate cancer, the disease grows very slowly. The majority of men with low-grade, early prostate cancer (confined to the gland) live a long time after their diagnosis. Even without treatment, many of these men will not die of the prostate cancer, but rather will live with it until they eventually die of some other, unrelated cause. Nevertheless, nearly 29,000 men will die of prostate cancer in 2003.

(source:NCI)



 


10/03/07 Dr. Potters to Chair Radiation Oncology at North Shore Healt...
07/19/07 NYPI helps sponsor fall car show...
06/02/07 NYPI Media Campaign...
04/24/07 Is survival better with seeds?...
Latest News

Contact | Web Statement | Privacy Policy | Legal Statement | Site Map | Home

New York Prostate Institute is now centered at Long Island Jewish Medical Center
270-05 76th Ave, New Hyde Park, NY 11040 718-470-7196 FX 718-470-0045
© 2010 New York Prostate Institute. All Rights Reserved.